BioCentury
ARTICLE | Clinical News

Alliance completes Phase III enrollment

May 31, 2000 7:00 AM UTC

ALLP completed enrollment of 484 patients in its European Phase III trial of Oxygent perflubron, an oxygen carrier intended to reduce the requirement for blood transfusions during surgery. The trial e...